Literature DB >> 1182067

A comparison of cytogenetics and histopathology in the malignant lymphomata.

S D Lawler, B R Reeves, I M Hamlin.   

Abstract

The non-Hodgkin's lymphomata are characteristically near diploid with occasional examples having higher chromosome numbers. In contrast, about half the cases of Hodgkin's disease have chromosome numbers in the triploid range. Karyotypes in cases of Hodgkin's disease appear to be more deranged than those found in other lymphomata, even when the cells are in the diploid range. If karyotypically normal cells in the tumours represent some degree of host reaction, then this is most marked in Hodgkin's disease. Long arm deletions of chromosome 18 were identified in cells from 7/31 cases of non-Hodgkin's lymphoma; 5 were follicular and 2 contained both follicular and diffuse areas. The cases showing this deletion had a relatively good prognosis.

Entities:  

Mesh:

Year:  1975        PMID: 1182067      PMCID: PMC2149596     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  2 in total

1.  Cytogenetics of malignant lymphomas. Studies utilising a Giemsa-banding technique.

Authors:  B R Reeves
Journal:  Humangenetik       Date:  1973-12-10

2.  A special role of the group 17,18 chromosomes in reticuloendothelial neoplasia.

Authors:  A S Spiers; A G Baikie
Journal:  Br J Cancer       Date:  1970-03       Impact factor: 7.640

  2 in total
  3 in total

1.  Malignant lymphomas.

Authors:  B H Tindle
Journal:  Am J Pathol       Date:  1984-07       Impact factor: 4.307

2.  Evidence that the Fc region of autologous rabbit IgG isolated before and after hyperimmunization is structurally different: recognition by rheumatoid factor and monoclonal antibodies.

Authors:  J S Murray; J C Brown
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Karyotype peculiarities of malignant lymphomas.

Authors:  E W Fleischman; E L Prigogina
Journal:  Hum Genet       Date:  1977-03-14       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.